# Trimas Corp: financial statements, quarterly

TRS · Nasdaq · CIK 842633 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trs.md) · [Financials](/companies/trs/financials.md) · [Filings](/companies/trs/filings.md) · [Insiders](/companies/trs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [235](/filings/0000842633-24-000078.md) | [(31.8) d](/filings/0000842633-26-000012.md) | [227](/filings/0000842633-25-000080.md) | [241](/filings/0000842633-25-000116.md) | [229](/filings/0000842633-25-000125.md) | [150](/filings/0000842633-26-000012.md) | [152](/filings/0000842633-26-000029.md) | [172](/filings/0000842633-26-000049.md) | [269](/filings/0000842633-25-000125.md) | [155](/filings/0000842633-26-000012.md) | [168](/filings/0000842633-26-000029.md) | [175](/filings/0000842633-26-000049.md) |
| Cost of revenue | $m | [179](/filings/0000842633-24-000078.md) | [(27.0) d](/filings/0000842633-26-000012.md) | [174](/filings/0000842633-25-000080.md) | [186](/filings/0000842633-25-000116.md) | [178](/filings/0000842633-25-000125.md) | [(37.3) d](/filings/0000842633-26-000012.md) | [120](/filings/0000842633-26-000029.md) | [134](/filings/0000842633-26-000049.md) | [203](/filings/0000842633-25-000125.md) | [(85.5) d](/filings/0000842633-26-000012.md) | [131](/filings/0000842633-26-000029.md) | [139](/filings/0000842633-26-000049.md) |
| Gross profit | $m | [55.9](/filings/0000842633-24-000078.md) | [(4.9) d](/filings/0000842633-26-000012.md) | [37.1](/filings/0000842633-26-000012.md) | [34.7](/filings/0000842633-26-000012.md) | [35.2](/filings/0000842633-26-000012.md) | [22.5](/filings/0000842633-26-000012.md) | [32.8](/filings/0000842633-26-000029.md) | [38.0](/filings/0000842633-26-000049.md) | [34.5](/filings/0000842633-26-000012.md) | [32.9](/filings/0000842633-26-000012.md) | [36.9](/filings/0000842633-26-000029.md) | [35.3](/filings/0000842633-26-000049.md) |
| Selling, general and administrative | $m | [32.3](/filings/0000842633-24-000078.md) | [(2.0) d](/filings/0000842633-26-000012.md) | [40.3](/filings/0000842633-25-000080.md) | [36.1](/filings/0000842633-25-000116.md) | [39.0](/filings/0000842633-25-000125.md) | [(5.7) d](/filings/0000842633-26-000012.md) | [31.0](/filings/0000842633-26-000029.md) | [30.5](/filings/0000842633-26-000049.md) | [41.1](/filings/0000842633-25-000125.md) | [5.1 d](/filings/0000842633-26-000012.md) | [30.0](/filings/0000842633-26-000029.md) | [24.5](/filings/0000842633-26-000049.md) |
| Operating income | $m | [23.8](/filings/0000842633-24-000078.md) | [(3.2) d](/filings/0000842633-26-000012.md) | [12.4](/filings/0000842633-25-000080.md) | [17.9](/filings/0000842633-25-000116.md) | [8.3](/filings/0000842633-25-000125.md) | [(23.4) d](/filings/0000842633-26-000012.md) | [7.2](/filings/0000842633-26-000029.md) | [7.4](/filings/0000842633-26-000049.md) | [16.6](/filings/0000842633-25-000125.md) | [(24.2) d](/filings/0000842633-26-000012.md) | [6.9](/filings/0000842633-26-000029.md) | [10.9](/filings/0000842633-26-000049.md) |
| Interest expense | $m | [4.0](/filings/0000842633-23-000118.md) | [4.3 d](/filings/0000842633-24-000004.md) | [4.9](/filings/0000842633-24-000053.md) | [5.2](/filings/0000842633-24-000072.md) | [4.9](/filings/0000842633-25-000125.md) | [4.6 d](/filings/0000842633-26-000012.md) | [4.5](/filings/0000842633-26-000029.md) | [4.6](/filings/0000842633-26-000049.md) | [4.4](/filings/0000842633-25-000125.md) | [4.6 d](/filings/0000842633-26-000012.md) | [5.2](/filings/0000842633-26-000029.md) | [4.1](/filings/0000842633-26-000049.md) |
| Income tax | $m | [3.2](/filings/0000842633-24-000078.md) | [(3.4) d](/filings/0000842633-26-000012.md) | [2.1](/filings/0000842633-25-000080.md) | [1.7](/filings/0000842633-25-000116.md) | [0.9](/filings/0000842633-25-000125.md) | [(6.9) d](/filings/0000842633-26-000012.md) | [0.7](/filings/0000842633-26-000029.md) | [0.7](/filings/0000842633-26-000049.md) | [2.8](/filings/0000842633-25-000125.md) | [(61.2) d](/filings/0000842633-26-000012.md) | [54.3](/filings/0000842633-26-000029.md) | [(49.2)](/filings/0000842633-26-000049.md) |
| Net income | $m | [16.5](/filings/0000842633-24-000078.md) | [7.9 d](/filings/0000842633-26-000012.md) | [5.1](/filings/0000842633-26-000012.md) | [10.9](/filings/0000842633-26-000012.md) | [2.5](/filings/0000842633-26-000012.md) | [5.6](/filings/0000842633-26-000012.md) | [12.4](/filings/0000842633-26-000029.md) | [16.7](/filings/0000842633-26-000049.md) | [9.3](/filings/0000842633-26-000012.md) | [81.7](/filings/0000842633-26-000012.md) | [801](/filings/0000842633-26-000029.md) | [13.4](/filings/0000842633-26-000049.md) |
| Diluted EPS | $ per share | [0.40](/filings/0000842633-24-000078.md) | not reported | [0.13](/filings/0000842633-26-000012.md) | [0.27](/filings/0000842633-26-000012.md) | [0.06](/filings/0000842633-26-000012.md) | [0.14](/filings/0000842633-26-000012.md) | [0.30](/filings/0000842633-26-000029.md) | [0.41](/filings/0000842633-26-000049.md) | [0.23](/filings/0000842633-26-000012.md) | [2.03](/filings/0000842633-26-000012.md) | [21.40](/filings/0000842633-26-000029.md) | [0.37](/filings/0000842633-26-000049.md) |
| Basic EPS | $ per share | [0.40](/filings/0000842633-24-000078.md) | not reported | [0.13](/filings/0000842633-26-000012.md) | [0.27](/filings/0000842633-26-000012.md) | [0.06](/filings/0000842633-26-000012.md) | [0.14](/filings/0000842633-26-000012.md) | [0.31](/filings/0000842633-26-000029.md) | [0.41](/filings/0000842633-26-000049.md) | [0.23](/filings/0000842633-26-000012.md) | [2.06](/filings/0000842633-26-000012.md) | [21.40](/filings/0000842633-26-000029.md) | [0.37](/filings/0000842633-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.7](/filings/0000842633-23-000118.md) | [34.9](/filings/0000842633-25-000015.md) | [30.5](/filings/0000842633-24-000053.md) | [35.0](/filings/0000842633-24-000072.md) | [26.9](/filings/0000842633-24-000078.md) | [23.1](/filings/0000842633-26-000012.md) | [32.7](/filings/0000842633-25-000080.md) | [30.3](/filings/0000842633-25-000116.md) | [33.6](/filings/0000842633-25-000125.md) | [30.0](/filings/0000842633-26-000049.md) | [1,310](/filings/0000842633-26-000029.md) | [1,242](/filings/0000842633-26-000049.md) |
| Current assets | $m | [407](/filings/0000842633-23-000118.md) | [397](/filings/0000842633-25-000015.md) | [428](/filings/0000842633-24-000053.md) | [439](/filings/0000842633-24-000072.md) | [435](/filings/0000842633-24-000078.md) | [427](/filings/0000842633-26-000012.md) | [465](/filings/0000842633-25-000080.md) | [489](/filings/0000842633-25-000116.md) | [483](/filings/0000842633-25-000125.md) | [463](/filings/0000842633-26-000049.md) | [1,590](/filings/0000842633-26-000029.md) | [1,547](/filings/0000842633-26-000049.md) |
| Total assets | $m | [1,342](/filings/0000842633-23-000118.md) | [1,342](/filings/0000842633-25-000015.md) | [1,364](/filings/0000842633-24-000053.md) | [1,366](/filings/0000842633-24-000072.md) | [1,368](/filings/0000842633-24-000078.md) | [1,324](/filings/0000842633-26-000012.md) | [1,394](/filings/0000842633-25-000080.md) | [1,445](/filings/0000842633-25-000116.md) | [1,434](/filings/0000842633-25-000125.md) | [1,485](/filings/0000842633-26-000049.md) | [2,297](/filings/0000842633-26-000029.md) | [2,246](/filings/0000842633-26-000049.md) |
| Current liabilities | $m | [158](/filings/0000842633-23-000118.md) | [159](/filings/0000842633-25-000015.md) | [157](/filings/0000842633-24-000053.md) | [156](/filings/0000842633-24-000072.md) | [154](/filings/0000842633-24-000078.md) | [159](/filings/0000842633-26-000012.md) | [165](/filings/0000842633-25-000080.md) | [189](/filings/0000842633-25-000116.md) | [180](/filings/0000842633-25-000125.md) | [184](/filings/0000842633-26-000049.md) | [328](/filings/0000842633-26-000029.md) | [284](/filings/0000842633-26-000049.md) |
| Total liabilities | $m | [667](/filings/0000842633-23-000118.md) | [659](/filings/0000842633-25-000015.md) | [691](/filings/0000842633-24-000053.md) | [690](/filings/0000842633-24-000072.md) | [685](/filings/0000842633-24-000078.md) | [657](/filings/0000842633-26-000012.md) | [707](/filings/0000842633-25-000080.md) | [730](/filings/0000842633-25-000116.md) | [709](/filings/0000842633-25-000125.md) | [779](/filings/0000842633-26-000049.md) | [847](/filings/0000842633-26-000029.md) | [803](/filings/0000842633-26-000049.md) |
| Long-term debt | $m | not reported | [400](/filings/0000842633-24-000004.md) | not reported | not reported | not reported | [402](/filings/0000842633-25-000015.md) | not reported | not reported | not reported | [473](/filings/0000842633-26-000012.md) | not reported | not reported |
| Current portion of debt | $m | not reported | [0.0](/filings/0000842633-24-000078.md) | not reported | not reported | [0.1](/filings/0000842633-24-000078.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [675](/filings/0000842633-23-000118.md) | [683](/filings/0000842633-25-000015.md) | [673](/filings/0000842633-24-000053.md) | [676](/filings/0000842633-24-000072.md) | [683](/filings/0000842633-24-000078.md) | [667](/filings/0000842633-26-000012.md) | [687](/filings/0000842633-25-000080.md) | [715](/filings/0000842633-25-000116.md) | [725](/filings/0000842633-25-000125.md) | [706](/filings/0000842633-26-000049.md) | [1,450](/filings/0000842633-26-000029.md) | [1,443](/filings/0000842633-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.4 d](/filings/0000842633-24-000078.md) | [30.6 d](/filings/0000842633-26-000012.md) | [(3.7)](/filings/0000842633-25-000080.md) | [18.4 d](/filings/0000842633-25-000116.md) | [22.0 d](/filings/0000842633-25-000125.md) | [27.1 d](/filings/0000842633-26-000012.md) | [9.2](/filings/0000842633-26-000029.md) | [30.3 d](/filings/0000842633-26-000049.md) | [36.5 d](/filings/0000842633-25-000125.md) | [41.5 d](/filings/0000842633-26-000012.md) | [(19.4)](/filings/0000842633-26-000029.md) | [(38.5) d](/filings/0000842633-26-000049.md) |
| Capital expenditure | $m | [10.0 d](/filings/0000842633-24-000078.md) | [19.3 d](/filings/0000842633-26-000012.md) | [13.3](/filings/0000842633-25-000080.md) | [10.9](/filings/0000842633-25-000116.md) | [11.9](/filings/0000842633-25-000125.md) | [15.0 d](/filings/0000842633-26-000012.md) | [12.9](/filings/0000842633-26-000029.md) | [12.1](/filings/0000842633-26-000049.md) | [13.7](/filings/0000842633-25-000125.md) | [4.7 d](/filings/0000842633-26-000012.md) | [5.2](/filings/0000842633-26-000029.md) | [6.5](/filings/0000842633-26-000049.md) |
| Dividends paid | $m | [1.7 d](/filings/0000842633-24-000078.md) | [1.7 d](/filings/0000842633-26-000012.md) | [1.7](/filings/0000842633-25-000080.md) | [1.7 d](/filings/0000842633-25-000116.md) | [1.7 d](/filings/0000842633-25-000125.md) | [1.7 d](/filings/0000842633-26-000012.md) | [1.6](/filings/0000842633-26-000029.md) | [1.7 d](/filings/0000842633-26-000049.md) | [1.7 d](/filings/0000842633-25-000125.md) | [1.7 d](/filings/0000842633-26-000012.md) | [1.5](/filings/0000842633-26-000029.md) | [1.5 d](/filings/0000842633-26-000049.md) |
| Share repurchases | $m | [0.3 d](/filings/0000842633-24-000078.md) | [5.4 d](/filings/0000842633-26-000012.md) | [13.3](/filings/0000842633-25-000080.md) | [3.5 d](/filings/0000842633-25-000116.md) | [2.4 d](/filings/0000842633-25-000125.md) | [0.0 d](/filings/0000842633-26-000012.md) | [0.5](/filings/0000842633-26-000029.md) | [1.8 d](/filings/0000842633-26-000049.md) | [0.0 d](/filings/0000842633-25-000125.md) | [101 d](/filings/0000842633-26-000012.md) | [54.5](/filings/0000842633-26-000029.md) | [18.9 d](/filings/0000842633-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [41.6](/filings/0000842633-24-000072.md) | [41.7](/filings/0000842633-24-000078.md) | [41.0](/filings/0000842633-26-000012.md) | [41.0](/filings/0000842633-26-000012.md) | [40.6](/filings/0000842633-26-000012.md) | [40.6](/filings/0000842633-26-000012.md) | [41.0](/filings/0000842633-26-000029.md) | [40.9](/filings/0000842633-26-000049.md) | [40.7](/filings/0000842633-26-000012.md) | [40.1](/filings/0000842633-26-000012.md) | [37.4](/filings/0000842633-26-000029.md) | [36.2](/filings/0000842633-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,873,873 at 2026-07-23, from the cover of the [10-Q filed 2026-07-31](/filings/0000842633-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.